IP Library Granted Patent US 11,039,958
Granted Patent B2
US 11,039,958 · App. 16/881,934 · Granted Jun 22, 2021

Methods and apparatuses for the treatment of glaucoma using visible and infrared ultrashort laser pulses

Inventor: Michael S. Berlin (West Hollywood, CA)
A61F9/00825A61F9/009A61F9/0084A61F2009/00851A61F2009/00865A61F2009/00868A61F2009/00891A61F2009/00897
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,039,958
App. No.
16/881,934
Granted
Jun 22, 2021
Kind
B2
Abstract

Transcorneal and fiberoptic laser delivery systems and methods for the treatment of eye diseases wherein energy is delivered by wavelengths transparent to the cornea to effect target tissues in the eye for the control of intraocular pressure in diseases such as glaucoma by delivery systems both external to and within ocular tissues. External delivery may be affected under gonioscopic control. Internal delivery may be controlled endoscopically or fiberoptically, both systems utilizing femtosecond laser energy to excise ocular tissue. The femtosecond light energy is delivered to the target tissues to be treated to effect precisely controlled photodisruption to enable portals for the outflow of aqueous fluid in the case of glaucoma in a manner which minimizes target tissue healing responses, inflammation and scarring.

Claims (16)

1. A method of creating a plurality of openings in a trabecular meshwork of a patient's eye to conduct fluid from an anterior channel into a Schlemm's canal of the eye, comprising:

ablating a first channel to a first depth in the trabecular meshwork adjacent to the Schlemm's canal with first laser pulses without entering the Schlemm's canal;

ablating a second channel to a second depth in the trabecular meshwork adjacent to the Schlemm's canal with second laser pulses without entering the Schlemm's canal;

extending the first channel with third laser pulses to a third depth and extending the second channel with fourth laser pulses to a fourth depth, wherein the first channel is extended to the third depth and the second channel is extended to the fourth depth after the second channel has been extended to the second depth, so as to penetrate an inner wall of the Schlemm's Canal, to form the plurality of openings to conduct fluid from the anterior channel to the Schlemm's canal, and to decrease optical pathway obscuration by blood reflux from the Schlemm's canal; and

wherein each of the laser pulses comprises a wavelength of within a range from 0.4 to 2.5 microns, a fluence level to produce optical breakdown, and a pulse duration in a range from 20 femtoseconds to 300 picoseconds.

2. The method of claim 1 , wherein the laser pulses are directed through a cornea of the eye to ablate the trabecular meshwork.

3. The method of claim 1 , wherein a gonioscopic lens is coupled to the eye and the laser pulses are transmitted through the gonioscopic lens.

4. The method of claim 1 , wherein the laser pulses are scanned in an ablation pattern of adjacent regions in the trabecular meshwork to form each of a plurality of channels, the plurality of channels comprising the first channel and the second channel, the pattern in the trabecular meshwork comprising a surface dimension within a range from 20 to 200 microns.

5. The method of claim 4 , wherein the plurality of channels is formed concurrently and wherein of the plurality of channels is subsequently extended to enter Schlemm's canal and to form the plurality of openings.

6. The method of claim 1 , wherein the laser pulses are reflected off a curved mirror and wherein the laser pulses are scanned and focused into a curved trabecular meshwork to form the plurality of openings in the curved trabecular meshwork.

7. The method of claim 1 , wherein an intraocular pressure of the eye is lowered to allow targeting Schlemm's canal and then elevated to prevent blood reflux.

8. The method of claim 1 , wherein Schlemm's canal is detected optically or by optical coherence tomography (OCT) or by photoacoustic spectroscopy.

9. The method of claim 1 , wherein the laser pulses are directed through a sclera of the eye to ablate the trabecular meshwork.

10. The method of claim 1 , wherein an intraocular pressure of the eye is lowered to allow targeting of Schlemm's canal.

11. The method of claim 1 , wherein an intraocular pressure of the eye is elevated to prevent blood reflux.

12. The method of claim 1 , wherein the laser pulses are reflected off a flat mirror to form the plurality of openings in the trabecular meshwork.

Continuity (5)
Continuation 16008917 · Jun 14, 2018
Continuation 14732627 · Jun 5, 2015
Continuation 13464949 · May 4, 2012
Provisional Application 61482824 · May 5, 2011
Related Publication 20200390604A1 · Dec 17, 2020
Cited By (8)
US 12,226,345 US 12,245,813 US 12,245,974 US 12,329,684 US 12,465,523 US 12,605,279 US 12,642,699 US 12,728,037